Urolithin A and Mitophagy: UK Ageing Evidence 2026

Published 2026-10-16 by the LongevityTortoise Research and Editorial Team. Last updated 2026-10-22.

What is urolithin A?

Urolithin A is a gut-microbiome metabolite produced when ellagitannins from pomegranates, walnuts, berries and some nuts are broken down. Not everyone makes it efficiently: genetics, age and gut flora affect conversion, so food alone is an unreliable source. As a supplement it has attracted attention because it activates mitophagy, the process by which cells recycle worn-out mitochondria.

What is mitophagy and why does it matter?

Mitochondria power most cellular processes, but they become damaged with age and produce more reactive oxygen species. Mitophagy selectively removes these faulty mitochondria and replaces them with healthier versions. Declining mitophagy is considered one of the cellular hallmarks of ageing, so compounds that can restore it are of interest to longevity research. Urolithin A is currently one of the most studied mitophagy activators available without a prescription.

Human evidence summary

Published human trials on urolithin A remain small or short-term. The strongest signals come from studies on sleep onset, oxidative stress markers, muscle endurance and metabolic health. Early phase I and II trials used doses of 500–1,000 mg/day, with the 1,000 mg dose used in the JAMA Network Open randomised trial in older adults looking at muscle endurance. We do not quote exaggerated effect sizes; instead, we flag the level of evidence and the size of each study where possible.

Urolithin A vs exercise for mitophagy

Exercise remains the most powerful and proven way to stimulate mitochondrial quality control. Urolithin A is sometimes framed as an "exercise mimetic", but the human data do not support replacing physical activity with a supplement. The more useful comparison is whether it may offer an additional signal for people who cannot exercise enough because of injury, illness or age-related frailty. Even then, the evidence is early and should be discussed with a clinician.

Potential benefits and targets

Safety and dosing for UK readers

There is no officially established UK Recommended Daily Allowance for urolithin A. Most products supply doses similar to those used in published studies, but individual needs vary. Short-term trials report a clean safety profile, with mild GI symptoms as the most common side effect. Long-term data beyond roughly a year are limited. Do not combine multiple supplements containing the same compound, and speak to a GP or pharmacist if you take prescription medication, have a liver or kidney condition, or are pregnant or breastfeeding.

How to choose a quality UK supplement

Look for third-party testing (e.g., certificates of analysis), clear ingredient labelling, and a UK-based or EU-compliant supplier. The label should state the actual milligrams of urolithin A, not total capsule weight or a pomegranate-extract equivalent. Avoid products that make explicit anti-ageing or disease-treatment claims, which are not permitted for food supplements in the UK.

Related LongevityTortoise guides